Philips Launches Alturion, an AI-Enhanced Ultrasound System with FDA and CE Approval
Royal Philips has announced the launch of Alturion, an ultrasound system equipped with AI-powered workflows designed for high-throughput clinical environments. The system has received FDA 510(k) clearance and CE certification, expanding access to advanced imaging and operational innovation.
A System Designed for High-Volume Clinical Settings
Alturion features a high-performance processing architecture that ensures responsiveness and clarity of visualization suited for various patient types and examinations. The system includes a 24-inch screen and a compact footprint, allowing for easy movement between departments and bedside. Streamlined workflows minimize manual adjustments and examination time, aiding in the management of high patient volumes. The familiar user interface supports operational simplification and consistency across clinical teams. Alturion integrates Elevate Plus with AI-assisted measurements for abdominal ultrasound, automating measurements and supporting exam reproducibility. These capabilities help reduce variability and time, contributing to more consistent examinations and supporting clinical decision-making.
Integration into Philips' Ultrasound Ecosystem
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Alturion is part of Philips' connected ultrasound ecosystem, sharing a common user interface and interchangeable transducers compatible with the EPIQ Elite and Affiniti systems. This compatibility allows sonographers and clinicians to use the same transducers across multiple systems, simplifying training and speeding up the integration of new users. Philips' general imaging ultrasound portfolio is designed for scalability and is compatible with Collaboration Live, a tele-ultrasound capability that allows multiple users to connect in real time for remote assistance, training, and consultation.
SectorSanté · Technologie · Dispositifs médicaux›Équipements Médicaux
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 1T2026
Key reported figures
Revenue: 3.9MD€
Free cash flow: 28M€
Guidance from the release
Nous avons délivré un bon départ en 2026.
Bonne performance au T1, croissance des ventes et des marges.
Risks mentioned
Impact des tarifs et inflation des coûts sur les marges.
Environnement macroéconomique incertain impactant les performances.
Opportunities identified
Croissance des ventes comparables de 4% dans tous les segments.
Augmentation du carnet de commandes grâce à des innovations.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.